INNOVATIONS. Tero Välimaa Ph.D., M.Sc. (Eng) FinnMedi BioneXt Tampere

Transcription

1 INNOVATIONS FOR WELLBEING Tero Välimaa Ph.D., M.Sc. (Eng) FinnMedi BioneXt Tampere 1

2 BioneXt BioneXt Tampere was a development and investment programme focusing on top- level research, product development, clinical application and international commercialization of biotechnology. The programme gathered together the strong and versatile technological expertise in the region to initiate new research in biology and medicine. The aim was to achieve investments to the value of 100 million euros by the year 2010.

3 BioneXt Investment goal: Three-fold the original aim Investments 270 million 3

4 Focal areas Immunology Financing Business Development Education Infrastructure Research R&D Clinical Trials Business Implants Bio-ICT 4

5 BioneXt spearhead enterprises Founded 5 research and development centres: 5

6 To turn Tampere into a capital of human spare parts, vaccine and biosensor know-how 6

7 Innovations with global significance are born from multidisciplinary cooperation Processing expertise Bioabsorbable Surgical Fixation Implants Orthopaedics Biomaterials

8 8

9 9

10 10

11 11

12 Tissue engineering and regenerative medicine First in the world: stem cells from fatty tissue grown into a jaw bone of the correct shape and size inside the patient s muscle 12

13 13

14

15 Pirkanmaa Hospital Disdrict Obduction Centre Patient Hotelli Hotel Coxa Uusi New obduktio obduction centre University Tampere of University Tampere Faculty Medical of Medicine School Tampere University Hospital TAYS

16 16

17 Leading centre of vaccine and infection research and business in Finland over 300 researchers Coordinating internationally significant clinical studies over vaccinated 17

18 Vaccines are growth business Largest big pharma companies are working together with research groups from Tampere Vactia brings together over 300 researchers and 30 million in projects 18

19 19

20 Biobank Headquarters FinTiB is the first hospital-associated biobank Leads the national biobank project The amount of biological information is growing exponentially Large business potential 20

21 Internationally unique environment Ophthalmology Tissue engineering Biosensors Stem cell treatments Human spare parts 4. generation multifunctional implants Personalised medicine (PPP) Effectiveness of healthcare Biomaterials Biobank Vaccines

22 Growth of personnel in life science enterprises The Life Science industry group has grown fastest in Tampere region compared to other regions in Finland BioneXt influence from 2005 Growth stagnated in 2008 due to the global financial crisis Helsinki Turku Oulu Kuopio Tampere Index year 2003= / / / / / / / / / /2009 Source: Statistics Finland

23 Business Development Systematic business incubator: 23 new companies Indirect influence: 49 new companies to healthcare sector 336 new companies in healthcare and wellness sector In 2006 over half of the incubator companies in Finland were found in Tampere Almost all of them companies heading for international markets Attracts foreign companies to establish their operations in Tampere 23

24 New jobs Bioretec Scaffdex ChipMan Technologies Biomire Dermagene FinTiB Stategics BCC ChiFi Novagenesis Salasade Ozics BioNavis STD-Tutkimus Tutor Invest Nanofoot Finland Vactech SILK Ovumia Arlion Motivon SenSem Vactia Rokotetutkimuskeskus Regea CliniXion IMT Therm Image icuris Pharma FIT-Biotech Tutor Partners HUR Labs Evostem Finland Histola Research

25 HealthBIO in Brief HealthBIO is a new Competence Cluster focusing on health-related biotechnology. The participating regions (capital region, Kuopio, Oulu, Tampere and Turku) represent the five major regional bioclusters in Finland. HealtBIO is financed by the Ministry of Internal Affairs as a part of the Center of Expertise Programme for the term of HealthBIO aims to build internationally attractive innovation environments by coordinated cooperation and networking of both regional and other national activities, and with a multidisciplinary approach to top level expertise and competencies.

26 HealthBIO - a cluster programme formed by the five main national biocenters in Oulu Oulu Innovation Ltd Tampere FinnMedi Oy Kuopio Teknia Ltd Turku Turku Science Park Ltd Capital region Culminatum Ltd Oy

27 More Information BioneXt Tampere HealthBIO Finn-Medi Tampere university hospital Tampere university of technology Tampere university Contact: Director Tero Välimaa, Ph.D., M.Sc. (Tech.) Finn-Medi Research Ltd Telephone: [email protected]